Mike Doustdar
Mike Doustdar has been appointed as the new CEO of Novo Nordisk, taking over from Lars Fruergaard Jørgensen on August 7, following a significant downward revision of the company's sales and operating profit expectations for 2025.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Denmark | 3 | 6.00 | 0.28% | +0% | 5,792,202 | 16,471 | $350,000 | 995$ |
| Australia | 1 | 5.00 | 0.09% | +0% | 25,499,884 | 23,611 | $1,380,000 | 1,278$ |
| Totals | 4 | 31,292,086 | 40,082 | $1,730,000 | 2,273$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Denmark:
Mike Doustdar explains the challenges Novo Nordisk faces in increasing revenue due to market competition and pricing pressures.
7
Denmark:
Mike Doustdar, the CEO of Novo Nordisk, explained that the forecast is a result of the company significantly lowering prices on its products.
6
Australia:
Chief executive Mike Doustdar said in a statement that Novo Nordisk will face pricing headwinds in an increasingly competitive market.
5
Denmark:
Mike Doustdar is the CEO of Novo Nordisk and acknowledges the challenges the company faces in 2026.
5
Hungary:
Mike Doustdar, the CEO of Novo Nordisk, stated that patients will receive a convenient daily tablet that can help lose as much weight as the original Wegovy injection.
8
United States:
Mike Doustdar, president and CEO of Novo Nordisk, stated that the Wegovy pill can help patients lose as much weight as the original Wegovy injection.
8
Cabo Verde:
Mike Doustdar is the president of the pharmaceutical company Novo Nordisk, which announced the approval of a new oral treatment for obesity.
8
Ecuador:
Mike Doustdar, president and CEO of Novo Nordisk, stated that the approval of the Wegovy pill will provide patients with a practical daily option for weight loss.
8
Denmark:
Mike Doustdar, the CEO of Novo Nordisk, is excited about the FDA approval of the Wegovy pill.
9
United Kingdom:
Securing the first weight-loss pill on the market will be critical for Mike Doustdar, who was appointed chief executive of Novo Nordisk this summer.
6